首页> 外国专利> METHOD FOR DETERMINING INDICATIONS FOR AN ANTI-ANGIOGENIC THERAPY OF MACULAR EDEMA IN POST-THROMBOTIC RETINOPATHY

METHOD FOR DETERMINING INDICATIONS FOR AN ANTI-ANGIOGENIC THERAPY OF MACULAR EDEMA IN POST-THROMBOTIC RETINOPATHY

机译:确定血栓后视网膜病变黄斑水肿的抗血管生成疗法适应症的方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, specifically to ophthalmology. Method for determining indications for conducting an anti-angiogenic therapy of macular edema in post-thrombotic retinopathy involves performing coherent optical tomography of the affected patient's macula, wherein thickness of central area of retina (TR), mm, and total volume of macula (VM), mm3, affected eye. Coefficient of readings (K) is calculated by formula: K=exp(-13.9+12.09×TR+0.33×VM)/[1+exp(-13.9+12.09×TR+0.33×VM)], where exp – exponential equal to 2.72. If condition 0.00039K≤0.75 is satisfied, anti-angiogenic therapy of macular edema in post-thrombotic retinopathy is considered to be indicated.;EFFECT: use of the invention enables higher accuracy of determining readings for the anti-angiogenic therapy of macular edema in post-thrombotic retinopathy.;1 cl, 2 ex
机译:技术领域本发明涉及医学,尤其涉及眼科。确定在血栓形成后视网膜病变中进行黄斑水肿抗血管生成治疗的适应症的方法包括对受影响患者的黄斑进行相干光学层析成像,其中视网膜中心区域的厚度(TR),mm和黄斑总体积(VM) ),mm 3 ,受影响的眼睛。读数系数(K)由以下公式计算:K = exp(-13.9 + 12.09×TR + 0.33×VM)/ [1 + exp(-13.9 + 12.09×TR + 0.33×VM)],其中exp –指数相等至2.72。如果满足0.00039 <K≤0.75的条件,则认为在血栓形成性视网膜病中指示了黄斑水肿的抗血管生成治疗。效果:本发明的使用使得确定用于黄斑水肿的抗血管生成治疗的读数的准确性更高。在血栓形成性视网膜病中; 1 cl,2 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号